Abstract

Sharpening the Preclinical Insight: Improve Clinical Relevance and Predictive Value

Sara Colombetti, Global Head Oncology Discovery Pharmacology, pharma Research and Early Development (pRED), Roche Innovation Center Zürich

We will present how the Pharmacology Group at the Roche Innovation Center Zurich has been developing over the past years a cutting edge mouse models platform for in vivo profiling of cancer immunotherapy combination. First internal Ph1 data will be also presented, which support the relevance of the pre-clinical model platform.